Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Pfizer    PFE

PFIZER

(PFE)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
08/15/2019 08/16/2019 08/19/2019 08/20/2019 08/21/2019 Date
34.48(c) 34.65(c) 35.18(c) 34.61(c) 35.1 Last
29 140 094 28 474 674 20 870 280 18 911 765 10 753 920 Volume
+0.70% +0.49% +1.53% -1.62% +1.42% Change
More quotes
Financials (USD)
Sales 2019 51 749 M
EBIT 2019 18 934 M
Net income 2019 11 493 M
Debt 2019 30 778 M
Yield 2019 4,14%
Sales 2020 48 888 M
EBIT 2020 17 955 M
Net income 2020 13 343 M
Debt 2020 29 952 M
Yield 2020 4,32%
P/E ratio 2019 15,0x
P/E ratio 2020 14,7x
EV / Sales2019 4,29x
EV / Sales2020 4,53x
Capitalization 191 B
More Financials
Company
Pfizer the world's leading pharmaceutical group. Net sales break down by family of products as follows: - vaccines, oncology products and consumer medicines (59.8%); - generic medicines (40.2%): for treating cardio-vascular diseases, nervous system disorders, infectious and respiratory diseases,... 
Sector
Pharmaceuticals
Calendar
10/29Earnings Release
More about the company
Surperformance© ratings of Pfizer
Trading Rating : Investor Rating :
More Ratings
Latest news on PFIZER
02:01pPFIZER : U.S. FDA Grants XTANDI® (enzalutamide) Application Priority Review for ..
BU
10:33aPFIZER : Sets $500 Million Gene-Therapy Expansion in Sanford, N.C.
DJ
10:03aPFIZER : Invests Half Billion Dollars to Advance State-of-the-Art Gene Therapy F..
BU
08:21aPFIZER : The Nature's Bounty Co. Names Faissal Tahiri as President, Internationa..
AQ
08/20THE PFIZER FOUNDATION : Invests in 20 Organizations Tackling Infectious Diseases..
BU
08/19Who is next in big pharma's merger spree?
RE
08/16FITCH RTGS : US Pharma M&A, Portfolio Reshaping, R&D Offset Growth Risk
AQ
08/15Pfizer Recalls Two Lots of Relpax Over Possible Contamination
DJ
08/14PFIZER : Issues A Voluntary Nationwide Recall For 2 Lots of RELPAX® (eletriptan ..
PU
08/14PFIZER : Oncolytics Biotech Reports 2019 Second Quarter Financial Results and Op..
AQ
More news
Analyst Recommendations on PFIZER
More recommendations
Sector news : Pharmaceuticals - NEC
12:46pLONDON STOCK EXCHANGE : Oil majors, exporters boost FTSE 100; Fed minutes eyed
RE
10:42aABBVIE : Form 8.3 -
DJ
10:29aTSX gains as energy shares rise on higher oil prices
RE
07:38aAstraZeneca Imfinzi combination fails advanced lung cancer study
RE
05:45aSlowing Share Buybacks Remove a Pillar of Stock Market
DJ
More sector news : Pharmaceuticals - NEC
Chart PFIZER
Duration : Period :
Pfizer Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 43,77  $
Last Close Price 34,61  $
Spread / Highest target 58,9%
Spread / Average Target 26,5%
Spread / Lowest Target -4,65%
EPS Revisions
Managers
NameTitle
Albert Bourla Director, Chief Executive & Operating Officer
Ian C. Read Executive Chairman
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Freda C. Lewis-Hall Chief Medical Officer & Executive Vice President
W. Don Cornwell Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER-19.40%191 430
JOHNSON & JOHNSON2.48%344 675
ROCHE HOLDING LTD.12.16%238 287
MERCK AND COMPANY12.09%219 296
NOVARTIS17.97%204 985
AMGEN4.37%121 841